The table below shows TANDEM DIABETES CARE INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$1.01B
$940.20M
$747.72M
$801.22M
$702.80M
$498.83M
Cost of revenue
$468.72M
$450.63M
$380.03M
$388.23M
$326.58M
$238.31M
Gross profit
$546.01M
$489.57M
$367.69M
$412.99M
$376.21M
$260.52M
R&D
-
-
-
-
$92.05M
$63.57M
TNDM annual revenue (10-K history)
TANDEM DIABETES CARE INC reported annual revenue of $1.01B for fiscal year 2025. That is up 7.9% from $940.20M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $84.25M (FY 2016) to $1.01B. Figures come from the company's audited annual reports as filed with the SEC.
